PTC Therapeutics, Inc.
PTCT
$75.25
-$0.92-1.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 124.51% | -107.48% | 1,415.24% | 38.22% | -7.54% |
| Total Depreciation and Amortization | 46.50% | 5.01% | 6.76% | 4.29% | -7.58% |
| Total Amortization of Deferred Charges | 0.99% | 1.00% | -2.61% | 2.33% | 1.69% |
| Total Other Non-Cash Items | -156.90% | -59.71% | 590.50% | -159.55% | -58.71% |
| Change in Net Operating Assets | -407.63% | 60.27% | -215.04% | 272.04% | 187.96% |
| Cash from Operations | -13.66% | -106.70% | 2,999.96% | 61.03% | -7.75% |
| Capital Expenditure | -161.58% | 23.61% | 54.23% | -621.65% | -107.08% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -100.00% | -99.94% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.97% | -130.26% | -167.30% | 743.76% | 58.38% |
| Cash from Investing | 31.37% | -128.90% | -168.87% | 727.33% | 35.27% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 324.89% | -74.85% | -40.50% | 4,519.72% | -87.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | 100.00% | -107.53% |
| Cash from Financing | 284.22% | -57.91% | -64.45% | 250.17% | -107.15% |
| Foreign Exchange rate Adjustments | -144.63% | 151.96% | 162.33% | -201.30% | 264.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.07% | -166.06% | 174.16% | 298.46% | -223.90% |